Skip to main content

Immunotherapy (Investigational Checkpoint)

16 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Immunotherapy (Investigational Checkpoint) (16)

Sabatolimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

TIM-3 / LAG-3 / TIGIT Inhibitor

Tiragolumab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Solid Tumour

Drug Class / Mechanism

TIGIT Inhibitor

Vibostolimab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Solid Tumour

Drug Class / Mechanism

TIGIT Inhibitor

Volrustomig

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Bispecific Checkpoint Antibody, PD-1 x CTLA-4